Ephedrine-type alkaloid-containing dietary supplements and substance dependence

被引：9
作者：
Miller, SC [1 ]
Waite, C [1 ]
机构：
[1] Wright Patterson Med Ctr, Wright Patterson AFB, OH 45433 USA
来源：
PSYCHOSOMATICS | 2003年 / 44卷 / 06期
关键词：
D O I：
10.1176/appi.psy.44.6.508
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：508 / 511
页数：4
相关论文
共 20 条
[1]  
[Anonymous], [No title captured]
[2]   Use of nonprescription weight loss products - Results from a multistate survey [J].
Blanck, HM ;
Khan, LK ;
Serdula, MK .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (08) :930-935
[3]  
CAPWELL RR, 1995, AM J PSYCHIAT, V152, P647
[4]   Content versus label claims in ephedra-containing dietary supplements [J].
Gurley, BJ ;
Gardner, SF ;
Hubbard, MA .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2000, 57 (10) :963-969
[5]   Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids. [J].
Haller, CA ;
Benowitz, NL .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (25) :1833-1838
[6]   Psychiatric complications of Ma-huang [J].
Jacobs, KM ;
Hirsch, KA .
PSYCHOSOMATICS, 2000, 41 (01) :58-62
[7]   USE, INDICATIONS AND DISTRIBUTION IN DIFFERENT COUNTRIES OF THE STIMULANT AND HALLUCINOGENIC AMPHETAMINE DERIVATIVES UNDER CONSIDERATION BY WHO [J].
KEUP, W .
DRUG AND ALCOHOL DEPENDENCE, 1986, 17 (2-3) :169-192
[8]   Seizure activity and unresponsiveness after hydroxycut ingestion [J].
Kockler, DR ;
McCarthy, MW ;
Lawson, CL .
PHARMACOTHERAPY, 2001, 21 (05) :647-651
[9]  
Kurt TL, 2000, J TOXICOL-CLIN TOXIC, V38, P351
[10]  
KURTZWEIL P, 1999, FDA GUIDE DIETARY SU
12